期刊文献+

新型靶向淋巴系统染料示踪剂的制备及其动物实验 被引量:2

Preparation and animal experiment of a new lymphatic-targeted dye tracer
原文传递
导出
摘要 目的基于毛细淋巴管与毛细血管孔径之间差别,设计并合成1种新型大分子淋巴特异性右旋糖酐与甲苯胺蓝偶合物染料示踪剂。方法以甲苯胺蓝为原料,右旋糖酐为载体制备大分子染料。兔颈部淋巴染色实验中,以甲苯胺蓝为阳性对照,对比2种染料相应颈部淋巴管、前哨淋巴结(SLN)染色时间,舌体扩散范围,并进行了病理组织学检查。结果制得平均分子粒径为200nm的新型大分子右旋糖酐和甲苯胺蓝偶合物淋巴染色示踪剂。新型大分子染料淋巴管平均染色时间(19.7min)大于阳性对照组(14.3min),SLN平均染色时间(>4周)大于对照组(<2d),舌体平均扩散范围(10.5mm)小于对照组(20.0mm)。结论新型大分子染料较常用活性染料甲苯胺蓝具有染色时间长,不易弥散,淋巴选择性高等特点。 Objective Based on the different diameters of the capillary lymphatic vessels and capillaries, a new macromolecular lymphatic tracer was designed and synthesized. Methods Using toluidine blue as starting material, dextran as carrier, the target macromolecular dextran-toluidine blue conjugates were obtained. With toluidine blue as positive control, the fading time and diffusion range of the new macro- molecular dextran-toluidine blue conjugates were evaluated in the animal experiments. Results the aver- age molecular size of the new macromolecular dextran-toluidine blue conjugates was 200 nm, and the average staining time was 19.7 minutes, more outweigh than the time of toluidine blue which was 14. 3 minutes. Its average diffusion range was 10. 5 mm, less than its positive control. Conclusion compared with the toluidine blue as a tracer, the macromolecular dextran-toluidine blue conjugates have obvious advantages such as longer staining time, less dispersion and can be taken up selectively by lymphatic system.
出处 《中国海洋药物》 CAS CSCD 北大核心 2013年第5期44-50,共7页 Chinese Journal of Marine Drugs
基金 国家自然科学基金项目(81172926)资助
关键词 示踪剂 淋巴管及淋巴结 活性组织检查 染色法 右旋糖酐 tracers lymphatic and lymph nodes biopsy staining dextran
  • 相关文献

参考文献15

  • 1Wittem H, Jone K, Wltng J, et al. Structure function rela-tionships in the lymphatic system and implications for cancerbiology [J]. Cancer Metastasis Rev, 2006, 25 (2): 159-184.
  • 2Padera T P, Kadambi A,Carreira C M, et al. Lymphaticmetastasis in the absence of functional intratumor lymphat-ics [J]. Science, 2002,296(5574) = 1883-1886.
  • 3Shoaib T, SoutarDS,MacDonaklDG, et al. The accuracyof head and neck carcinoma sentinel lymph node biopsy inthe clinically NO neck [J]. Cancer,2001,91 (10) : 2077-2083.
  • 4Yudd A P, Kempf J S,Goydos T J,et al. Use of sentinelnode lymphoscintigraphy in malignant melanoma[J]. Radi-ographics j 1999,19: 343-353.
  • 5李国杰,陈慕华,田兴松.乳腺癌前哨淋巴结活检术的临床应用与进展[J].医学信息(手术学分册),2007,20(6):535-538. 被引量:2
  • 6BovStick P J Giuliano A E. Vital dyes in sentinel node locali-zation CJj. Semin Nucl Med,2000,30: 18-24.
  • 7孙玥,吴晶,万升标,刘世恩,冯元勇,尚伟,江涛.靶向淋巴系统造影剂的制备及其动物实验[J].中国科学:化学,2011,41(11):1712-1718. 被引量:8
  • 8吴元魁,陈斌,马著彬,彭旭红,许乙凯,黄其鎏.钆喷替酸葡甲胺-白蛋白制备及其在MR淋巴造影中的应用[J].中国组织工程研究与临床康复,2009,13(38):7547-7550. 被引量:1
  • 9Desser T S,Rubin D L, Muller H H,et al. Dynamics oftumor imaging with Gd-DTPA-polyethylene glycol poly-mers: Dependence on molecular weight [J]. Magn ResonImaging,1994, 4: 467-472.
  • 10Duarte M G, Gil M H,Peters J A, et al. Synthesis* char-acterization, and relaxivity of two linear Gd (DTPA)-poly-mer conjugates [J], Bioconjugate Chem,2001. 12 : 170-177.

二级参考文献54

  • 1王水,范萍,刘晓安,武正炎.乳腺癌骨髓和前哨淋巴结微小转移检测的临床研究[J].中华普通外科杂志,2004,19(9):570-571. 被引量:5
  • 2徐晓明,赵祥生,周建农,唐金海,陈环球,张彤,周大庆,莫伏根,秦建伟,姜爱仁.前哨淋巴结检测在乳腺癌治疗中的意义[J].中华普通外科杂志,2004,19(8):494-495. 被引量:12
  • 3俞开潮,万福贤,杨献,张焱.靶向性磁共振成像造影剂的研究进展[J].化学试剂,2004,26(6):329-332. 被引量:3
  • 4张保宁,宣立学,张涛,王仲照,陈国际,易进,刘淋,陈盛祖.乳腺癌前哨淋巴结活检的实践与体会[J].中华普通外科杂志,2005,20(11):704-706. 被引量:30
  • 5中华人民共和国科学技术部.关于善待实验动物的指导性意见.2006.09-30
  • 6Aime S, Gianolio E, Terreno E, et al. Ternary Gd(Ⅲ)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI. J Biol Inorg Chem. 2000; 5(4): 488-497.
  • 7Ruehm SG, SchroederT, Debatin JF. Interstitial MR lymphography with gadoterate meglumine: initial experience in humans. Radiology. 2001;220(3):816-821.
  • 8Kosuda S, Kusano S, Kohno N, et al. Feasibitity and cost-effectiveness of sentinel lymph node radiolocalization in stage NO head and neck cancer. Arch Otolaryngel Head Neck Surg. 2003;129(10):1105-1109.
  • 9[10]Imoto S,Murakami K,Ikeda H,et al.Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer[J].Ann Nucl Med,1999,13:325-329.
  • 10[11]Borgstein PJ,Pijpers R,Comans EF,et al.Sentinel lymph node biopsy in breast cancer:guidelines and pitfalls of lymphoscintigraphy and gamma probe detection[J].J Am Coll Surg,1998,186:275-283.

共引文献8

同被引文献55

  • 1韩晓峰,任予,许建林,施常备.放射性硫胶体应用于乳腺癌前哨淋巴结活检的可行性分析[J].中华临床医师杂志(电子版),2012,6(16):4863-4864. 被引量:4
  • 2刘晶莹,郑玉峰.PAMAM树状大分子磁共振成像造影剂的研究进展[J].材料导报,2007,21(5):69-72. 被引量:3
  • 3俞海平,周正扬,朱斌,陈君坤.淋巴造影技术的动物实验研究[J].生物医学工程与临床,2007,11(6):434-437. 被引量:1
  • 4Zhang F, Niu G, Lu G M, et al. Preclinical lymphatic ima- ging[J]. Mol Imaging Biol, 2011, 13(4) : 599-612.
  • 5Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis[J]. J Cell/Vlol IVied, 2009, 13(8A).. 1405-16.
  • 6Saban M R, Memet S, Jackson D G, et al. Visualization of lymphatic vessels through NF- kappaB activity[J]. Blood, 2004, 104(10): 3228-30.
  • 7Moriguchi P, Sannomiya P, L.ara P F, et al. Lymphatic sys- tem changes in diabetes mellitus., role of insulin and hyper- glycemiaI-J~. Diabetes Metab Res Rev, 2005, 21(2): 150- 157.
  • 8Harvey N L, Srinivasan R S, Dillard M E, et al. Lymphatic vascular defects promoted by Proxl haploinsufficiency cause adult- onset obesity[J]. Nat Genet, 2005, 37 (10): 1072- 1081.
  • 9Ruchi S, Juliet A W, John C R,et al. New horizons for ima- ging lymphatic functionEJ]. Ann N Y Acad Sci, 2008, 1131: 13-36.
  • 10Rodrigues E B, Costa E F, Penha F M, et al. The use of vi- tal dyes in ocular surgery[J]. Surv Ophthalmol, 2009, 54 (5) : 576-617.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部